|
ANVS Annovis Bio Inc 1477845 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-14,820,815.00 |
| Balance Sheet |
|
Current Assets
|
$7,813,295.00 |
|
Assets
|
$22,037,091.00 |
|
Current Liabilities
|
$6,358,709.00 |
|
Liabilities
|
$26,291,709.00 |
|
Equity
|
$-4,254,618.00 |
|
Shares Out
|
42606152.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-30,925,244.00 |
| Market Analysis |
Market Cap
|
$76,265,012.08 |
|
Price
|
$1.79 |
|
BVPS
|
0.11 |
|
PB
|
16.27 |
|
EPS
|
-0.40 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:52 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:43 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ANVS documents filed with the SEC.
ANVS Filings
Clear
